Evidence map›Paper›PMID 30197529›Full record

ArticleClinical and experimental gastroenterology2018

Liver function tests in identifying patients with liver disease.

Zohair Ahmed, Umair Ahmed, Saqib Walayat, Jinma Ren, Daniel K Martin, Harsha Moole, Sean Koppe, Sherri Yong, Sonu Dhillon

Open access · goldAbstract read
In one paragraph

Article in Clinical and experimental gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 97 citations in OpenAlex.

  1. Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Review
  2. Article
  3. Dynamic Liver Function Tests in Paediatric Liver Disease.Diagnostics (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zohair AhmedDepartment of Gastroenterology and Hepatology, University of Illinois, Chicago, IL, USA, Zahmed23@uic.edu.
Umair AhmedDepartment of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USA.
Saqib WalayatDepartment of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USA.
Jinma RenDepartment of Center for Outcomes Research, University of Illinois College of Medicine, Peoria, IL, USA.
Daniel K MartinDepartment of Gastroenterology and Hepatology, University of Illinois College of Medicine, Peoria, IL, USA.
Harsha MooleDepartment of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USA.
Sean KoppeDepartment of Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
Sherri YongDepartment of Pathology, University of Illinois College of Medicine, Peoria, IL, USA.
Sonu DhillonDepartment of Gastroenterology and Hepatology, University of Illinois College of Medicine, Peoria, IL, USA.
Illinois College · USUniversity of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsMany patients with liver disease come to medical attention once they have advanced cirrhosis or acute decompensation. Most often, patients are screened for liver disease via liver function tests (LFTs). There is very limited published data evaluating laboratory values with biopsy-proven stages of hepatic fibrosis. We set out to evaluate whether any correlation exists between routine LFTs and stages of hepatic fibrosis.

methodsA large retrospective observational study on 771 liver biopsies was conducted for evaluating the stage of fibrosis with AST, ALT, INR, BUN, creatinine, platelets, alkaline phosphatase, bilirubin, and albumin. Mean and 95% confidence intervals were used to describe the distributions of serum markers in different fibrosis stages. Multivariable generalized linear models were used and a two-tailed

resultsALT was not statistically significant for any stage, and AST was statistically significant for stage 3 and 4 fibrosis. INR was statistically significant only in stage 4 disease but remained near the upper limit of normal range. Albumin failed to show a clinically relevant association. Platelets remained within normal laboratory range for all stages. The remaining laboratory values failed to show statistical and clinical significance.

conclusionThe health care burden from chronic liver disease (CLD) will likely continue to rise, unless clinicians are made aware that normal or near normal laboratory findings may be seen in asymptomatic patients. Earlier identification of asymptomatic patients will allow for treatment with new promising modalities and decrease morbidity and mortality from CLD. Our study shows that laboratory values correlate poorly with liver disease.

Indexed as

chronic liver diseasecirrhosisHCVhepatic fibrosisNAFLDserum markers

Identifiers

PMID30197529
PMCPMC6112813
OpenAlexW2888028761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.